There are 297 resources available
139TiP - Neoadjuvant MAP in patients aged 24-40 years with osteosarcoma under the coverage of hemodialysis: Ongoing trial
Presenter: Anastasia Tararykova
Session: Poster Display session
Resources:
Abstract
140TiP - Brightline-4: A phase III open-label, single-arm, multicentre study to assess the safety and efficacy of brigimadlin (BI 907828), an MDM2-p53 antagonist, in patients with treatment-naïve or pretreated advanced dedifferentiated liposarcoma
Presenter: Scott Schuetze
Session: Poster Display session
Resources:
Abstract
141TiP - Cemiplimab treatment in patients with locally advanced and metastatic secondary angiosarcomas (CEMangio): A phase II clinical trial in progress
Presenter: Ingrid Desar
Session: Poster Display session
Resources:
Abstract
142TiP - SARC-Digital: An obServational, rAndomized, pRospeCtive study of the impact of digital health interventions on symptom and side-effect management in patients with metastatic sarcoma
Presenter: Stefania Kokkali-Zervos
Session: Poster Display session
Resources:
Abstract
143P - Molecular profiling and treatmentrelated outcomes with chemo-immunotherapy in patients with mucosal melanoma: A 10-year single-centre retrospective study
Presenter: Prashant Jambunathan
Session: Poster Display session
Resources:
Abstract
144P - Influence of tumor-infiltrating T-cells' characteristics on the survival of patients with primary choroid melanoma
Presenter: Iryna Zherka
Session: Poster Display session
Resources:
Abstract
145P - Real-world evidence on thymic epithelial tumours (TETs): A decade of surgical experience and recurrence outcomes
Presenter: Spyridon Gennatas
Session: Poster Display session
Resources:
Abstract
148P - The impact of desmoid tumors on patients' quality of life: Desmoid Tumor Research Foundation Natural History Study
Presenter: Amanda Lucas
Session: Poster Display session
Resources:
Abstract
149P - Treatment landscape for desmoid tumors: Desmoid Tumor Research Foundation Natural History Study
Presenter: Amanda Lucas
Session: Poster Display session
Resources:
Abstract
150P - Sorafenib is an active and cost-effective treatment modality in patients with symptomatic desmoid tumors
Presenter: DIEGO Soriano Polo
Session: Poster Display session
Resources:
Abstract